Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To investigate the safety, tolerability and pharmacokinetics of BI 425809 tablets in healthy Chinese and Japanese male subjects following the administration of single rising oral doses and further to explore the pharmacokinetics (PK) including dose proportionality of BI 425809 after single dosing of product.
Epistemonikos ID: 368e9d73f77ecd5e538d29c218a79b4c2211e740
First added on: May 12, 2024